373 related articles for article (PubMed ID: 21971709)
21. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
[TBL] [Abstract][Full Text] [Related]
22. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
23. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
24. CD133+ niches and single cells in glioblastoma have different phenotypes.
Christensen K; Schrøder HD; Kristensen BW
J Neurooncol; 2011 Aug; 104(1):129-43. PubMed ID: 21184132
[TBL] [Abstract][Full Text] [Related]
25. Proliferation of vascular smooth muscle cells in glioblastoma multiforme.
Takeuchi H; Hashimoto N; Kitai R; Kubota T; Kikuta K
J Neurosurg; 2010 Aug; 113(2):218-24. PubMed ID: 19929197
[TBL] [Abstract][Full Text] [Related]
26. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
[TBL] [Abstract][Full Text] [Related]
27. The Adenosine A₃ Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia.
Rocha R; Torres Á; Ojeda K; Uribe D; Rocha D; Erices J; Niechi I; Ehrenfeld P; San Martín R; Quezada C
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670017
[TBL] [Abstract][Full Text] [Related]
28. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
29. Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.
Saito N; Aoki K; Hirai N; Fujita S; Iwama J; Hiramoto Y; Ishii M; Sato K; Nakayama H; Harashina J; Hayashi M; Izukura H; Kimura H; Ito K; Sakurai T; Yokouchi Y; Oharazeki T; Takahashi K; Iwabuchi S
Brain Tumor Pathol; 2015 Jul; 32(3):176-83. PubMed ID: 25665548
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
31. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a GM7 glioblastoma cell line showing CD133 positivity and both cytoplasmic and nuclear localization of nestin.
Loja T; Chlapek P; Kuglik P; Pesakova M; Oltova A; Cejpek P; Veselska R
Oncol Rep; 2009 Jan; 21(1):119-27. PubMed ID: 19082452
[TBL] [Abstract][Full Text] [Related]
33. CD133 identifies perivascular niches in grade II-IV astrocytomas.
Christensen K; Schrøder HD; Kristensen BW
J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
[TBL] [Abstract][Full Text] [Related]
34. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.
Beck S; Jin X; Yin J; Kim SH; Lee NK; Oh SY; Jin X; Kim MK; Kim EB; Son JS; Kim SC; Nam DH; Kim SH; Kang SK; Kim H; Choi YJ
Biomaterials; 2011 Nov; 32(33):8518-28. PubMed ID: 21880363
[TBL] [Abstract][Full Text] [Related]
35. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
[TBL] [Abstract][Full Text] [Related]
36. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro.
Birnbaum T; Hildebrandt J; Nuebling G; Sostak P; Straube A
J Neurooncol; 2011 Oct; 105(1):57-65. PubMed ID: 21547397
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
Yi L; Zhou ZH; Ping YF; Chen JH; Yao XH; Feng H; Lu JY; Wang JM; Bian XW
Mod Pathol; 2007 Oct; 20(10):1061-8. PubMed ID: 17660801
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of CD133 and nestin in patients with glioma: a population-based study.
Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW
Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750
[TBL] [Abstract][Full Text] [Related]
39. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
40. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
